Showing results (1-10 of 4,426) with videos related to
Sort By:
Pageof 443
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Modeling Parkinson's disease in primates: The MPTP modelGregory Porras, Qin Li, Erwan BezardCold Spring Harbor Perspectives in Medicine|June 10, 2024
Modeling Parkinson's Disease in PrimatesErwan Bezard, Margaux Teil, Marie-Laure Arotcarena, et al.Animal Models and Experimental Medicine|March 21, 2019
Microdialysis in awake macaque monkeys for central nervous system pharmacokineticsThibaud Thiollier, Caisheng Wu, Gregory Porras, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesiaErwan Bezard, Elisabetta Tronci, Elsa Y Pioli, et al.Behavioural Pharmacology|August 31, 2006
Traditional Chinese medicine for Parkinson's disease: a review of Chinese literatureQin Li, Deming Zhao, Erwan BezardScientific Reports|January 17, 2014
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatumGregory Porras, Philippe De Deurwaerdere, Qin Li, et al.Neuroscience Letters|February 28, 2014
Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's diseaseWai Kin D Ko, Qin Li, Erwan BezardNeuroscience Letters|December 29, 2007
Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's diseaseDieter Scheller, Christine Stichel-Gunkel, Hermann Lübbert, et al.Journal of Neuroscience Methods|December 21, 2019
Models of hyperkinetic disorders in primatesErwan BezardBehavioural Pharmacology|August 31, 2006
A call for clinically driven experimental design in assessing neuroprotection in experimental ParkinsonismErwan BezardPageof 443